University of Eastern Finland
ACED (Advanced Human-Based Concept for Efficient Drug Development)
FROM PRESS RELEASE: The project utilises technology and screening methods that are based on patient stem cells and humanised animal models, creating preconditions for the commercialisation of brain disease treatments which are based on inflammatory reaction control. These treatments have been developed by Koistinaho together with Associate Professor Tarja Malm and Docent Katja Kanninen at the A.I. Virtanen Institute for Molecular Sciences.
Further info at: Jari Koistinaho, Professor of Stem Cell Research, PI of the ACED project, tel. +358 40 355 2427, firstname.lastname@example.org